DIKER MANAGEMENT LLC

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1276525 New York, NY

Position in SPRY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$524,719

+$255,650 QoQ

Shares Held

65,508

+95.5% QoQ

Ownership

0.066%

of shares outstanding

% of Portfolio

0.40%

of 13F equity value

Holder Rank

#73

of 208 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

DIKER MANAGEMENT LLC holds $721,359 across 4 Biotechnology names. SPRY ranks #1 (72.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SPRY	ARS Pharmaceuticals, Inc. This page	65,508	$524,719
2	VNDA	Vanda Pharmaceuticals Inc.	21,880	$133,905
3	LXRX	Lexicon Pharmaceuticals, Inc.	20,000	$48,000
4	JSPR	Jasper Therapeutics, Inc.	35,000	$14,735

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$524,719	65,508	+95.5%	Shares	Sole	2026-08-14
2026-03-31	$269,069	33,508	0.0%	Shares	Sole	2026-05-15
2025-12-31	$390,368	33,508	-23.0%	Shares	Sole	2026-02-17
2025-09-30	$437,255	43,508	+6.1%	Shares	Sole	2025-11-14
2025-06-30	$715,450	41,000	+95.2%	Shares	Sole	2025-08-14
2025-03-31	$264,180	21,000	—	Shares	Sole	2025-05-22
No filing history on record for this holder in this stock.